Giovanni Tomasello

Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest

Chiara Cremolini, Fotios Loupakis, C. Antoniotti et al. · Annals of Oncology · 2015 · 194 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO

Emanuela Dell’Aquila, Chiara Cremolini, Tea Zeppola et al. · Annals of Oncology · 2018 · 134 citations · Full text

Medicine, Immunology, Oncology +17

The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study

Vincenzo Davide Palumbo, Marcello Romeo, Antonella Marino et al. · Biomedical Papers · 2016 · 131 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

HSP-molecular chaperones in cancer biogenesis and tumor therapy: an overview.

Francesca Rappa, Felicia Farina, Giovanni Zummo et al. · PubMed · 2012 · 128 citations

Life Sciences, Molecular Biology, Oncology +15

Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO

Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi et al. · Annals of Oncology · 2018 · 110 citations · Full text

Medicine, Oncology, Pharmacotherapy +15